In addition, the overlapped targets of miR-196a were enriched in several pathways including glioma, focal adhesion, ECM–receptor interaction, gap junction, prostate cancer, GnRH signaling pathway, melanogenesis, and insulin signaling pathway (Table 3). This evidence concerns the gene INS and prostate carcinoma.